Digital health case studyPharmaceutical
Identifying Ventures With Proven Digital Biomarker Scoring Capability
Client context: Global pharmaceutical
Strategic question
Which ventures have a proven, differentiated digital biomarker scoring algorithm in oncology?
Approach
Powered by HealthTech Alpha, we evaluated 110 ventures across eight priority markets, applied client criteria to build a prioritised list of 15, and mapped their strategic partnerships to pinpoint the most engagement-ready.
Strategic implication
Replaced noisy marketing claims with a comparative, evidence-based view of who genuinely has the capability.
